Rockville, MD, February 15, 2024—ABL, a Rockville based CDMO, announced today that it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET–H, a dynamic nationwide network of organizations launched by the Advanced Research Projects Agency for Health (ARPA-H).  ARPA-H’s overarching mission to improve health outcomes through the following research focus areas: health science futures, proactive health, scalable solutions, and resilient systems. Investor Catalyst Hub spokes represent a broad spectrum of expertise, geographic diversity, and community perspectives.

Based in the Greater Boston area and managed by VentureWell, the Investor Catalyst Hub seeks to accelerate the commercialization of groundbreaking and accessible biomedical solutions. It utilizes an innovative hub-and-spoke model designed to reach a wide range of nonprofit organizations and Minority-Serving Institutions, with the ultimate aim of delivering scalable healthcare outcomes for all Americans.

As an Investor Catalyst Hub spoke, ABL gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spoke membership also offers opportunities to provide input on ARPA-H challenge areas and priorities, along with access to valuable networking opportunities and a robust resource library.

“It is a wonderful opportunity for ABL to contribute to the ARPA-H’s overarching mission of improving health outcomes”- said, Dr. Fouts, Chief Scientific Officer at ABL.  “The flexible contracting offered should promote collaborations across the member organizations to speed up the delivery of solutions from bench to bedside” – said, Ana Daniels, Sr. Director of Legal and Contracts at ABL.

Advanced BioScience Laboratories, Inc

9800 Medical Center Drive, Building D

Rockville, MD 20850

Contact: Timothy R. Fouts, Ph.D.

Phone: 301-816-5453

Email: Timothy.Fouts@ablinc.com